Sonnet BioTherapeutics Launches $583M Hyperliquid Treasury, Fueling HYPE Token Price Speculation
Sonnet BioTherapeutics Holdings, Inc., a Nasdaq-listed biopharmaceutical company, alongside Rorschach, has launched a $583 million Hyperliquid treasury initiative. This significant move involves Hyperliquid Strategies Inc. holding 12.6 million HYPE tokens alongside a $305 million cash reserve, positioning the entity to… Read More »Sonnet BioTherapeutics Launches $583M Hyperliquid Treasury, Fueling HYPE Token Price Speculation